Vasopressor
9
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
33%
3 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine
Canadian Critical Care Comparative Effectiveness Platform
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia
ImPortance of Arterial Measurement Sites (IPAMS) on Intraoperative Hemodynamic Management
Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis
Postoperative Vasopressor Usage: SQUEEZE
Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A
Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension